세계 의료 검체 추적 시스템 시장은 예측 기간(2025-2032년) 동안 8.98%의 연평균 복합 성장률(CAGR)을 나타내고, 2024년 10억 223만 달러에서 2032년 19억 9,408만 달러에 달할 것으로 예측됩니다. 이 시장의 성장은 임상시험 수 증가, 워크플로우를 개선하고 인적 오류를 줄이기 위한 실험실의 자동화 요구 확대, 인공지능(AI) 및 머신러닝 알고리즘의 통합을 포함한 추적 시스템의 발전에 기인합니다.
또한, 오진 및 의료 실수의 가능성을 줄이기 위해 의료 검체 추적 시스템에 대한 요구가 증가하고 있습니다. 추적 시스템은 또한 지연이 결과를 위태롭게 할 수 있는 다양한 문제를 야기할 수 있기 때문에 의료 전문가가 제때에 처리할 수 있도록 지원합니다.
또한, 임상 연구가 확대됨에 따라 생물학적 시료의 효율적인 관리, 모니터링, 운송, 수집 및 분석에 대한 수요가 증가하여 시장 수요를 촉진하고 있습니다. 임상시험에서는 대량의 시료가 발생하기 때문에 규제 준수를 보장하고 서로 다른 연구시설 간의 협력을 유지하기 위해 면밀한 추적이 필요한 경우가 많습니다. 이러한 상황에서 추적 시스템은 시료의 취급 및 식별 오류를 최소화하면서 복잡한 물류를 처리하는 데 중요한 역할을 합니다.
적용되는 모든 지역 및 국가에 대해 모든 부문이 제공됩니다.
상기 기업은 시장 점유율 순서가 아니며, 분석 작업중에 입수한 정보에 따라서 변경될 가능성이 있습니다.
Global medical specimen tracking systems market is projected to witness a CAGR of 8.98% during the forecast period 2025-2032, growing from USD 1002.23 million in 2024 to USD 1994.08 million in 2032. The market's growth can be attributed to the rising number of clinical trials, the rising requirement for automation in laboratories to improve workflow and reduce human error, and advancements in tracking systems, including the integration of artificial intelligence (AI) and machine learning algorithms.
Additionally, the requirement for medical specimen tracking systems is also increasing to reduce the chances of misdiagnosis and medical errors. Tracking systems also aid medical professionals in ensuring that they are processed on time, as delays can result in a wide range of challenges that can jeopardize the results.
Moreover, as clinical research expands, the demand for efficient management, monitoring, transportation, collection, and analysis of biological specimens is increasing, propelling the market's demand. Clinical trials generate large volumes of specimens that often require meticulous tracking to ensure regulatory compliance and maintain coordination across different research sites. In such situations, tracking systems play a crucial role in handling complex logistics while minimizing errors in specimen handling and identification.
Increasing Requirement for Diagnostic Tests Boosts Market Demand
The rising reliance on diagnostic tests can be attributed to the growing burden of various chronic diseases and disorders in different regions across the globe. The American Cancer Society estimates that over 2 million new cancer cases will be reported in the United States in 2025. As medical professionals and laboratories handle complex testing processes and high sample volumes, the requirement for automated tracking systems to prevent misidentification and workflow management is rising. Medical specimen tracking systems aid laboratories in maintaining sample integrity, ensuring the delivery of results in a time-efficient manner with the help of automated alerts and real-time location tracking, and reducing the risk of contamination. Additionally, digital health initiatives and government-backed healthcare modernization programs are pushing hospitals to adopt these systems to meet regulatory compliance and improve patient safety outcomes.
Rising Emphasis on Laboratory Automation Supports Market Expansion
Laboratories are increasingly seeking automated solutions to streamline sample collection, transport, and analysis processes. Medical specimen tracking systems have become essential for supporting automation in clinical labs by ensuring every sample is accurately logged, located, and matched with the right patient data. These systems reduce manual errors, minimize sample losses, and improve staff productivity. Technological advancements, such as integration with laboratory information systems (LIS), real-time dashboards, and mobile apps, are making specimen tracking more accessible and scalable across varied healthcare settings. Automated sample tracking helps laboratories meet the increasing demand for high-throughput testing. As testing capacities scale up, laboratories require reliable systems to maintain quality and traceability.
Furthermore, regulatory authorities such as the United States Food and Drug Administration (US FDA) and the European Medicines Agency emphasize the need for secure and verifiable chain-of-custody procedures, further prompting the adoption of automated specimen tracking systems. Thus, leading companies are investing in research and development to introduce intelligent specimen-tracking software equipped with predictive analytics, AI-based sorting mechanisms, and real-time audit trails. For instance, in January 2023, Becton, Dickinson and Company launched a new robotic track system to support flexible and custom lab automation configuration to meet the unique and evolving requirements of laboratories.
RFID-Based Tracking Systems Account for Significant Share of the Market
RFID systems offer significant advantages over traditional barcoding, such as improved read rates, automation of inventory tracking, and the ability to track multiple specimens simultaneously without direct line-of-sight, supporting the segment's expansion. These benefits are particularly valuable in large-scale hospital and laboratory environments where speed, accuracy, and sample security are critical. RFID-enabled tracking also supports temperature monitoring during specimen transport, which is vital for preserving the integrity of sensitive biological samples. Additionally, the relatively low costs of RFID tags and readers are making technology more accessible to mid-sized and smaller healthcare institutions.
Due to the rising requirements for RFID-based systems, the leading players in the market are focusing on launching new solutions to meet the different requirements of the healthcare and life science sectors. For instance, in March 2024, TMRW Life Sciences, Inc. launched a new digital specimen management system that contains an RFID tracking chip and intuitive specimen management software to provide a unique off-site storage experience.
North America Holds a Major Market Share
The rapid growth of the market in North America can be attributed to the presence of leading market players and well-established healthcare industry, stringent regulatory requirements for specimen handling, and early adoption of digital technologies by the healthcare sector. High investments in healthcare IT, along with increasing focus on patient safety and operational efficiency, are further driving the demand for advanced tracking solutions in clinical laboratories and hospitals across the United States and Canada. Additionally, the rise in the number of clinical trials and growing focus on research and development activities are also propelling the market's expansion in North America. As of 23rd May 2025, 158,176 studies are registered in the United States at ClinicalTrials.gov, the publicly available registry and results database, run by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).
Future Market Scenario (2025-2032F)
The market is expected to witness significant growth over the forecast period due to rising awareness about patient safety and sample integrity, increasing diagnostic workload, and growing lab automation. The growing popularity of personalized medicines, the expansion of biobanks, and the increase in complex sample workflows in clinical trials are expected to propel the market's demand.
Ongoing research and development activities in combination with strategic partnerships and collaborations between healthcare institutions, laboratories, and technology providers are expected to drive innovations and ensure the availability of technologically advanced solutions. The next generation of medical specimen tracking systems is going to be defined by improved user interface and blockchain-backed traceability solutions.
Key Players Landscape and Outlook
The key players in the market are investing in real-time tracking, cloud-based platforms, AI-powered solutions, and automation to improve the efficiency, accuracy, and security of specimen-tracking processes across diagnostic centers, hospitals, and laboratories. Several market players are participating in partnerships and collaborations and mergers and acquisitions to meet the rising demand for traceability solutions in the healthcare industry and expand their global footprint. For instance, in November 2023, Cryoport Systems, LLC acquired Bluebird Express, LLC to expand its global supply chain network. The acquisition is allowing Cryoport to improve its service coverage across the United States and foster innovations in specimen tracking solutions, allowing the company to expand its presence in the industry.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.